ISDA

Deposition Date 2009-11-16

Release Date 2010-12-01

Last Version Date 2024-11-13

Entry Detail

PDB ID:

2WYG

Keywords:

BLOOD CLOTTING

Title:

Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.88 Å

R-Value Free:

0.23

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:ACTIVATED FACTOR XA HEAVY CHAIN
Gene (Uniprot):F10
Chain IDs:A
Chain Length:254
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:FACTOR X LIGHT CHAIN
Gene (Uniprot):F10
Chain IDs:B
Chain Length:134
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Ligand Molecules

461

Primary Citation

Structure and Property Based Design of Factor Xa Inhibitors: Pyrrolidin-2-Ones with Monoaryl P4 Motifs

Kleanthous, S, Borthwick, A.D, Brown, D, Burns-Kurtis, C.L, Campbell, M, Chaudry, L, Chan, C, Clarte, M, Convery, M.A, Harling, J.D, Hortense, E, Irving, W.R, Irvine, S, Pateman, A.J, Patikis, A, Pinto, I.L, Pollard, D.R, Roethka, T.J, Senger, S, Shah, G.P, Stelman, G.J, Toomey, J.R, Watson, N.S, Whittaker, C, Zhou, P, Young, R.J.Show

Bioorg.Med.Chem.Lett. 20 618 ? (2010)

PMID: 20006499 DOI: 10.1016/J.BMCL.2009.11.077

Abstact

Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa inhibitors, incorporating neutral and basic monoaryl P4 groups, ultimately producing potent inhibitors with effective levels of anticoagulant activity and extended oral pharmacokinetic profiles. However, time dependant inhibition of Cytochrome P450 3A4 was a particular issue with this series.

Legend

Protein

Chemical

Disease

Primary Citation of related structures